![Claudio Ullmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Claudio Dansky Ullmann formerly worked at Takeda Pharmaceutical Co., Ltd., as Senior Medical Director from 2012 to 2015, MaxCyte, Inc., as Chief Medical Officer, Infinity Pharmaceuticals, Inc., as Senior Vice President-Clinical Development, Avenge Bio, Inc., as Chief Medical Officer, and Context Therapeutics, Inc., as Chief Medical Officer from 2024 to 2025.
Dr. Ullmann received his graduate degree from Universidad de Buenos Aires.
Tidigare kända positioner av Claudio Ullmann
| Företag | Position | Slut |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-05-10 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2015-01-01 |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Teknisk/Vetenskaplig/F&U Direktör | - |
| MAXCYTE, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
| INFINITY PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Claudio Ullmanns utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
17
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
